|  Recent 
        figures indicate that India’s pharmaceutical industry will grow 
        to $55 billion by 2020. With export of pharmaceutical products to 
        more than 200 countries, India expects to cross the Rs one trillion (U.S.$16.17 
        billion) mark this year. According to Pharmaceutical Export Promotion 
        Council (Pharmexcil), the growth would be around 15 percent and will be 
        driven by formulation exports. During 2013-14, pharma exports stood at 
        Rs 90,000 crore (US$ 14.55 billion). Of this, the share of formulations 
        was 71 percent while the other categories were drug intermediates, Active 
        Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (FDFs), 
        bio-pharmaceuticals, and clinical services.
 
 
 Pharmaceutical airfreight is expected to grow 
        at a faster pace than general cargo.
 This has led many carriers to start new facilities 
        for this fast growing segment.
 Airlines have already started ramping up flights 
        out of India. Qatar Airways Cargo, for example, recently announced the 
        launch of the seventh freighter destination in the country,
 Last month on February 3, Qatar Airways Cargo 
        commenced freighter services to Ahmedabad in Gujarat.
 The city has textiles, chemicals, automobiles, 
        and pharmaceuticals industries and over the last few years it has seen 
        a growth in biotechnology with the presence of more than 50 biotechnology 
        companies and around 66 support organizations.
 Incidentally, Qatar Airways is the only international 
        carrier to provide freighter services to Ahmedabad.
 
 
 Last year, IAG Cargo introduced B787s in its 
        London Heathrow and Hyderabad, Chennai flights.      
             The B787s have helped the pharma industry.
 The plane’s forward cargo hold has air 
        conditioning, making it ideal for shipping temperature-sensitive pharmaceutical 
        products.
 This has made IAG Cargo the only European operator 
        to offer daily flights on these routes.
 
 For their part, airport authorities have brought 
        in equipment and created facilities at some of India’s major international 
        airports. Two airports—Mumbai International Airport (MIAL) and Delhi 
        International Airports Ltd. (DIAL)—have upgraded the air cargo facilities 
        to handle 80-90 percent of the export and import trade of pharmaceuticals.
 In association with the Organization of Pharmaceutical 
        Producers of India (OPPI), the custodians of the two airports have taken 
        initiatives to do away with the bottlenecks that delay the transport process.
 Among the enhancements are the creation of cold 
        room space, training and refresher courses for the staff that handle pharma 
        products at the airport, and storage.
 In fact, MIAL has installed four new cold rooms 
        for pharmaceuticals while DIAL has enhanced the cold room capacity considerably.
 Meanwhile, other airports are getting into the 
        act.
 At the international airport at Vishakhapatnam 
        recent introduction of direct flights from Visakhapatnam to Kuala Lumpur 
        by Malindo Air has given rise to speculation amongst larger pharma exporters 
        that a proper air cargo terminal at the airport—with special facilities 
        for pharma exports—will be put up.
 In addition to the privately held international 
        airports, the government has also taken major steps.
 
 
 The India Brand Equity Foundation (IBEF)—a 
        trust established by the government’s Ministry of Commerce and Industry 
        with the primary objective to promote and create international awareness 
        of the ‘Made in India’ label in markets overseas—recently 
        announced the efforts being made by the pharmaceutical industry and the 
        government to sustain the export growth trajectory.
 The focus will now be on Argentina, which has 
        of late opened up its U.S.$6 billion drug market to Indian companies. 
        The move will raise the country’s present contribution of around 
        8 percent to the Latin American region.
 Other moves include a more export-friendly ecosystem 
        for the Indian pharmaceutical industry. One of the first few countries 
        to launch the Trace and Track mechanism for its pharma products, India 
        has started putting barcodes on the primary, secondary, and tertiary level 
        packaging labels in phases.
 In fact, the system is already in place at the 
        secondary and tertiary level of packaging.
 Tirthankar Ghosh
 |